Cargando…

Ongoing Risk of Unrelated Donors Testing Positive for COVID-19 Following Medical Clearance and Impact on Operations: A Report from the National Marrow Donor Program

Detalles Bibliográficos
Autores principales:	Stefanski, Heather E., Novakovich, Jennifer, Newman, Jennifer, Snyder, Christian, Cody, Meghann, Oakes, Jason, Nielson, Amy, Auletta, Jeffery James, Miller, John P., Devine, Steven M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2023
Materias:	Poster Session: Donor Safety, Unique Mobilizations, and Health Services
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899542/ http://dx.doi.org/10.1016/S2666-6367(23)00299-3

Ejemplares similares

Impact of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Peripheral Blood Progenitor Cell Collections in Canada
por: Seftel, Matthew, et al.
Publicado: (2023)

Neither COVID-19, Nor Cryopreservation, Prevented Allogeneic Product Infusion: A Report from the National Marrow Donor Program
por: Stefanski, Heather E., et al.
Publicado: (2021)

Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program
por: Farhadfar, Nosha, et al.
Publicado: (2022)

Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products
por: Auletta, Jeffery J., et al.
Publicado: (2021)

The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022)

Donor and non‐donor perspectives on receiving information from routine genomic testing of donor blood
por: Thorpe, Rachel, et al.
Publicado: (2022)

Assessing the discrimination of the Kidney Donor Risk Index/Kidney Donor Profile Index scores for allograft failure and estimated glomerular filtration rate in Ireland’s National Kidney Transplant Programme
por: Sexton, Donal J, et al.
Publicado: (2019)

Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care
por: Colunga-Pedraza, Perla Rocío, et al.
Publicado: (2021)

Do deferred donors continue their donations? A large‐scale register study on whole blood donor return in the Netherlands
por: Spekman, Marloes L.C., et al.
Publicado: (2019)

Incorporating apolipoprotein L1 testing into evaluation of potential living kidney donors: a single-centre experience
por: Dick, Jonathan, et al.
Publicado: (2019)

Deferral rate variability in blood donor eligibility assessment
por: de Kort, Wim, et al.
Publicado: (2018)

Prevalence of DNA of fourteen human polyomaviruses determined in blood donors
por: Kamminga, Sergio, et al.
Publicado: (2019)

Sexual risk behavior questions: Understanding and mitigating donor discomfort
por: Haw, Jennie, et al.
Publicado: (2021)

Plasmavigilance—Adverse events among US Source plasma donors
por: Schreiber, George B., et al.
Publicado: (2021)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Risk of hematological malignancy in blood donors: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

Cryopreservation of Allogeneic Hematopoietic Cell Grafts Did Not Adversely Impact Early Post-Transplant Survival during the First Six Months of the COVID-19 Pandemic
por: Devine, Steven M., et al.
Publicado: (2022)

Ensuring HLA‐matched platelet support requires an ethnic diverse donor population
por: Kreuger, Aukje L., et al.
Publicado: (2020)

First results of a ferritin‐based blood donor deferral policy in the Netherlands
por: Vinkenoog, Marieke, et al.
Publicado: (2020)

Detection of dengue, chikungunya, and Zika RNA in blood donors from Southeast Asia
por: Stanley, Jean, et al.
Publicado: (2020)

Human T‐lymphotropic virus in Irish blood donors: Impact on future testing strategy
por: Williams, Pádraig, et al.
Publicado: (2022)

Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay
por: Levin, Andrew E, et al.
Publicado: (2014)

Trends and risk factors of SARS‐CoV‐2 infection in asymptomatic blood donors
por: Valenti, Luca, et al.
Publicado: (2021)

Communicating the move to individualized donor selection policy: Framing messages focused on recipients and safety
por: Ferguson, Eamonn, et al.
Publicado: (2022)

Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors
por: Wong, Horas Tze Hoo, et al.
Publicado: (2015)

Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay
por: Levin, Andrew E., et al.
Publicado: (2016)

Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy
por: Spekman, Marloes L.C., et al.
Publicado: (2020)

How to increase first‐time donors' returns? The postdonation letter's content can make a difference
por: Moussaoui, Lisa S., et al.
Publicado: (2022)

Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram
por: Hartmann, Jan, et al.
Publicado: (2021)

High prevalence of human T‐cell leukemia virus type‐1b genotype among blood donors in Gabon, Central Africa
por: Ramassamy, Jill‐Léa, et al.
Publicado: (2020)

Evidence of likely autochthonous Chagas disease in the southwestern United States: A case series of Trypanosoma cruzi seropositive blood donors
por: Lynn, Mary K., et al.
Publicado: (2022)

COVID19 seroconversion in an unrelated stem cell donor
por: Maakaron, Joseph E., et al.
Publicado: (2020)

Recruiting unrelated donors for the National Marrow Donor Program.
por: Yanke, D. R.
Publicado: (1990)

Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
por: Wendel, Silvano, et al.
Publicado: (2020)

‘Stay at home and limit contact’: The impact of stay‐at‐home advice on the behavior of Australian donors aged 70 and over in the first year of the pandemic
por: Naing, Sanda, et al.
Publicado: (2022)

Estimation of the number of blood donors during the COVID‐19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission
por: Yuan, Zhaohu, et al.
Publicado: (2020)

New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS‐CoV‐2
por: Spekman, Marloes L. C., et al.
Publicado: (2021)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada
por: Lambert, Gilles, et al.
Publicado: (2022)

Non-Utilization of Cryopreserved Stem Cell Products from Unrelated Donors during the COVID-19 Pandemic
por: Buk, Deborah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_58bqtp22nt5tvobuovbhq6trqf